News Daily News Rivaroxaban Falls Flat in Antiphospholipid Antibody Syndrome Todd Neale October 15, 2019
News Features Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis? Michael O'Riordan February 01, 2019